Rejuran i
With a lower viscosity than REJURAN® Classic and REJURAN® s, REJURAN® i has been specifically formulated for use in the delicate periorbital area. It is designed to support improvements in the appearance of fine lines, wrinkles and overall skin quality around the eyes. REJURAN® i is administered into the periorbital area by a trained healthcare professional, with the treatment approach determined following an individual consultation and assessment. A typical REJURAN® i treatment uses 1 mL of solution, with the volume and treatment approach determined according to the individual’s needs and the practitioner’s clinical assessment.
Learn more about REJURAN® i here.
Treatment Information
- Treatment Type
- Injection
- Results
- REJURAN® i is commonly selected by individuals seeking to enhance under eye skin quality, to address areas where the skin may appear thin, dehydrated, uneven in texture or lacking resilience. The treatment is designed to support gradual improvements in the appearance of skin quality, texture and vitality, while maintaining a natural-looking result. A complete treatment plan is advised.
- Longevity of Effect
- The duration of results can vary between individuals, however improvements may continue for six months to a year after a treatment plan. Additional maintenance sessions may be considered following the initial treatment plan, subject to consultation with the treating practitioner.
- Number of Sessions
- REJURAN® is not a one-size-fits-all solution — individual treatment plans and results vary. A minimum of 3 sessions is recomended.
- Interval Between Sessions
- Individual treatment plans and results vary, typically 3 week interval is recomended
- Downtime
- 1 to 3 days
- Possible Reactions
- Minor redness, injection marks, swelling and skin sensitivity, which generally subside within 1-3 days, minor flaking, dryness and peeling, which may last several days. Scabs may form but generally fall off within a few days. Infections may occur, which in rare cases could lead to scarring (such as from picking), REJURAN® can be administered on the same day as cross-linked hyaluronic acid (HA), provided each product is injected in different tissue planes. Rare occurrences of granuloma may occur if other cross-linked HA fillers are injected in the same plane. Patients should discuss possible reactions, side effects and any concerns with their treating practitioner, who can provide advice based on their individual circumstances, medical history and the relevant product information.
- Pain Level
- Moderate
- After-care
- After the procedure it is recommended to avoid high-temperature environments such as saunas and steam rooms. Do not excessively massage the treated area. Apply a broad-spectrum sunscreen (SPF 50 or higher) to minimise pigmentation risk.
* This information has been provided by the clinic or owner of the device, not FABshaping.
Reviews for Rejuran i
No reviews yet. Be the first after your visit.